September 17, 2025
229
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
4:08Now PlayingOn this episode of Stock Movers:
- Novo Nordisk received an upgrade to buy from hold at Berenberg, which switches its preferences within the obesity sector to make the Danish company its top pick instead of Eli Lilly.
- Morgan Stanley upgraded Centrica's stock to an overweight, or buy, rating. Their analyst made Centrica the new top pick within UK utilities. The shares aren’t even fully valuing its existing business, let alone potential upside from deals including Sizewell C and the Grain LNG terminal, a note said.
- Inditex gained to outperform peers as UBS raised the recommendation on the Zara owner to buy from neutral. Analysts at UBS said they felt confident in its long term growth following a strong start to the autumn-winter season.
See omnystudio.com/listener () for privacy information.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies making news on Wall Street.
Check out more episodes of Stock Movers
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Television
Bloomberg Originals
For coverage on news, markets and more
#Stocks #Markets #Finance #Investing #Podcast #Bloomberg
Novo Nordisk Rises, Centrica Gains, Inditex Up
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.